RaQualia Pharma Inc. (TYO:4579)
Japan · Delayed Price · Currency is JPY 856.00
-28.00 (-3.17%)
Apr 17, 2026, 3:30 PM JST
RaQualia Pharma Market Cap
RaQualia Pharma has a market cap or net worth of 22.27 billion as of April 17, 2026. Its market cap has increased by 133.14% in one year.
Market Cap
22.27B
Enterprise Value
21.93B
Revenue
3.98B
Ranking
n/a
PE Ratio
75.35
Stock Price
856.00
Market Cap Chart
Since July 20, 2011, RaQualia Pharma's market cap has increased from 19.90B to 22.27B, an increase of 11.91%. That is a compound annual growth rate of 0.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 22.27B | -9.84% |
| Dec 30, 2025 | 24.70B | 194.57% |
| Dec 30, 2024 | 8.39B | -43.62% |
| Dec 29, 2023 | 14.87B | -42.44% |
| Dec 30, 2022 | 25.84B | 5.05% |
| Dec 30, 2021 | 24.60B | 17.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Japan Tissue Engineering | 24.98B |
| Stella Pharma | 24.27B |
| AnGes | 22.95B |
| Renascience | 19.54B |
| StemRIM | 19.49B |
| ReproCELL | 17.11B |
| CanBas | 14.22B |
| Immuno-Biological Laboratories | 14.06B |